New drug combo aims to wipe out stomach bug in phase 3 trial
NCT ID NCT06751121
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tested a new three-drug combination (DWP14012-based triple therapy) against a standard treatment to see if it can safely and effectively eliminate Helicobacter pylori, a bacteria that can cause stomach ulcers. 461 adults with confirmed H. pylori infection took part. The goal was to check if the new treatment works as well as the current one, especially in cases where the bacteria are resistant to common antibiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.